Tarka (trandolapril / verapamil) Drug Interactions
A total of 1083 drugs (5616 brand and generic names) are known to interact with Tarka (trandolapril / verapamil).
- 215 major drug interactions (1031 brand and generic names)
- 783 moderate drug interactions (4228 brand and generic names)
- 85 minor drug interactions (357 brand and generic names)
Check for interactions with Tarka (trandolapril / verapamil)
Common medications checked in combination with Tarka (trandolapril / verapamil)
- Ambien (zolpidem)
- Aspirin Low Strength (aspirin)
- Celebrex (celecoxib)
- clonidine
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- grapefruit
- hydrochlorothiazide
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- metformin
- Nexium (esomeprazole)
- pravastatin
- simvastatin
- spinach
- Synthroid (levothyroxine)
- trazodone
- Vitamin D3 (cholecalciferol)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Tarka (trandolapril / verapamil) alcohol/food Interactions
There are 4 alcohol/food interactions with Tarka (trandolapril / verapamil)
Tarka (trandolapril / verapamil) disease Interactions
There are 21 disease interactions with Tarka (trandolapril / verapamil) which include:
- Angioedema
- Bone Marrow Suppression
- Chf
- Hemodialysis
- Hyperkalemia
- Hypotension
- Aortic Stenosis
- Bradyarrhythmia/Av Block
- Cardiogenic Shock/Hypotension
- Coronary Artery Disease
- Liver Disease
- Ventricular Tachycardia
- Cirrhosis
- Accessory Av Tracts
- Chf/Ami
- Hypertrophic Cardiomyopathy
- Liver Disease
- Renal Dysfunction
- Neuromuscular Transmission
- Renal Dysfunction
- Gi Narrowing
More about Tarka (trandolapril / verapamil)
- Tarka Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: ACE inhibitors with calcium channel blocking agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
